Voxelotor (GBT440), a first ‐in‐class hemoglobin oxygen‐affinity modulator, has promising and reassuring preclinical and clinical data

Source: American Journal of Hematology - Category: Hematology Authors: Tags: Commentary Source Type: research
More News: Hematology